Chemistry Wealth Management’s Arch Capital ACGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$989K Buy
10,187
+218
+2% +$20.6K 0.16% 89
2026
Q1
$957K Buy
9,969
+558
+6% +$53.4K 0.17% 83
2025
Q4
$903K Sell
9,411
-602
-6% -$55.1K 0.17% 85
2025
Q3
$908K Buy
10,013
+109
+1% +$9.77K 0.18% 82
2025
Q2
$902K Buy
9,904
+1,125
+13% +$104K 0.19% 79
2025
Q1
$844K Buy
8,779
+1,356
+18% +$125K 0.2% 77
2024
Q4
$686K Buy
7,423
+1,450
+24% +$146K 0.16% 83
2024
Q3
$668K Buy
5,973
+654
+12% +$68K 0.16% 89
2024
Q2
$537K Buy
5,319
+890
+20% +$86.5K 0.14% 93
2024
Q1
$409K Buy
+4,429
New +$374K 0.11% 107

Other funds holding ACGL

Chemistry Wealth Management's ACGL Position: Q2 2026 in Review

Chemistry Wealth Management increased its Arch Capital (ACGL) stake by 2.2% in Q2 2026, buying an estimated $20.6K and bringing the position to 10,187 shares worth $989K. The position accounts for 0.16% of the portfolio, ranked #89.

Chemistry Wealth Management first reported a position in ACGL in Q1 2024 and has held it in 10 quarters since. 355 funds tracked by Wall St. Rank hold ACGL as of Q2 2026.

  • Chemistry Wealth Management held 10,187 shares of Arch Capital worth $989K as of Q2 2026.
  • Chemistry Wealth Management bought 218 Arch Capital shares in Q2 2026, an estimated $20.6K.
  • Arch Capital made up 0.16% of Chemistry Wealth Management's portfolio in Q2 2026, its #89 holding.
  • Chemistry Wealth Management first reported a position in Arch Capital in Q1 2024 and has held it in 10 quarters since.
  • 355 funds tracked by Wall St. Rank held Arch Capital as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.